Karyopharm Therapeutics competitorsClear all
Karyopharm Therapeutics's top competitors include Halozyme Therapeutics, Celltrion Healthcare, Nektar Therapeutics and Pharmacyclics.
| Save Comparison |  Karyopharm Therapeutics Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases. |  Halozyme Therapeutics Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | |
Founding Date | Founding Date 2008 | Founding Date 1998 | Founding Date 2002 | Founding Date 1990 | Founding Date 1991 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Newton, US HQ München, DE Tel Aviv Yafo, IL | Locations San Diego, US HQ | Locations KR HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Sunnyvale, US HQ |
Employees | Employees 472 | Employees 1363% increase | Employees 6301% increase | Employees 61821% increase | Employees 8801% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 6.1 b | Valuation ($) N/A | Valuation ($) 3.2 b | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 217 | Twitter followers 599 | Twitter followers 1.3 k | Twitter followers 1.2 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 22 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) 17 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1.7 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 5 | Average likes per tweet (last 30 days) 1.9 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 95.45% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 35.29% |
Alexa Website Rank | Alexa Website Rank 351923 | Alexa Website Rank 368474 | Alexa Website Rank 520383 | Alexa Website Rank 248913 | Alexa Website Rank 296065 |
Employee Rating | Employee Rating 3.9 | Employee Rating 3.3 | Employee Rating N/A | Employee Rating 3.3 | Employee Rating 3.3 |
Financial | |||||
Revenue (est.) | Revenue (est.) $108.1m (FY, 2020) | Revenue (est.) $267.6m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $152.9m (FY, 2020) | Revenue (est.) $729.7m (FY, 2014) |
Cost of goods | Cost of goods N/A | Cost of goods $43.4m (FY, 2020) | Cost of goods N/A | Cost of goods $19.5m (FY, 2020) | Cost of goods $40.4m (FY, 2014) |
Gross profit | Gross profit N/A | Gross profit $224.2m (FY, 2020) | Gross profit N/A | Gross profit $133.4m (FY, 2020) | Gross profit $689.3m (FY, 2014) |
Net income | Net income ($196.3m) (FY, 2020) | Net income $129.1m (FY, 2020) | Net income N/A | Net income ($444.4m) (FY, 2020) | Net income $86.1m (FY, 2014) |
Funding | |||||
Total funding raised | Total funding raised $ 248.7m | Total funding raised $ 45m | Total funding raised N/A | Total funding raised $ 45m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Halozyme Therapeutics
HQ
San Diego, US
Employees
136↑ 3% increase
Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View companyCelltrion Healthcare
HQ
KR
Employees
630↑ 1% increase
Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,
View company
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company